Form 4 for AMLX Amylyx Pharmaceuticals, Inc.
Accepted 2023-03-20 00:00:00 ET · period of report 2023-03-16 · accession 0000899243-23-009172 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-20 | 2023-03-16 | AMLX | Firestone Karen | Dir | P - Purchase | $31.99 | +1,000 | 1,000 | New | +$32.0K |
| D | 2023-03-20 | 2023-03-16 | AMLX | Firestone Karen | Dir | A - Grant | $0.00 | +27.4K | 27.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-16 | P | A | 1,000 | $31.99 | 1,000 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.96 to $32.00. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-03-16 | A | A | 27,403 | $0.00 | 27,403 | D | $32.08 · — to 2033-03-16 | 27,403 Common Stock | (F2) One-third of the shares subject to the option shall vest on the first anniversary of the date of grant, and the remaining two-thirds will vest in equal monthly installments over two years, provided, however, that all vesting shall cease if the director resigns from the Board or otherwise ceases to serve as a director of the Issuer. |